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Abstract
This thesis studies the two fundamental mechanisms of bacterial evolution— horizontal gene transfer
and spontaneousmutation, in the bacterium Escherichia coli through novel experimental assays andmathe-
matical simulations. First, I will develop a growth assay utilizing the quantitative polymerase chain reaction
(qPCR) to provide real-time enumeration of genetic marker abundance within bacterial populations. Sec-
ond, I will focus on horizontal gene transfer in E. coli occurring through a process called conjugation. By
fitting the qPCR data to a resource limited, logistic growth model, I will obtain estimated values of several
key parameters governing the dynamics of DNA transfer through conjugation under two diﬀerent condi-
tions: i) in the absence of selection; ii) in the presence of negative selection pressure — bacteriophage
infection. Last, I will investigate spontaneousmutation through qPCR assay of competition betweenwild-
type and mutator phenotype E. coli. Mutator phenotype has an elevated mutation rate due to defects in
DNA proofreading and repairing system. By introducing antibiotic selective pressure, I will examine the
fixation probability of mutators competing with wild-type in novel environment. I also will utilize simula-
tions to study the impact of three parameters on the fixation probability.
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1
Introduction
In 1928, Alexander Fleming, Professor of Bacteriology at St. Mary’s Hospital in London, came
back from holiday and was sorting through his petri dishes containing bacterium Staphylococcus. He no-
ticed mold was growing on one culture plate, which was not too unusual. But what surprised him was the
area immediately around the mold was clear, as if something secreted by the mold had killed the bacte-
ria. Later the mold was identified as a rare strain of Penicillium notatum, and the bacteria killing compound
penicillin became the first identified antibiotic [1]. From then on, more andmore antibiotics were discov-
ered along the way that greatly reduced the number of deaths resulting from bacterial infections. However,
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this human scientific triumph has been shadowed by nature’s counterforce — antibiotic resistance. The
U.S. Centers for Disease Control and Prevention (CDC) states in its Antibiotic Resistance Threats in the
United States, 2013 Report [2]:
Antimicrobial resistance is one of our most serious health threats… Each year in the United
States, at least 2 million people acquire serious infections with bacteria that are resistant to
one or more of the antibiotics designed to treat those infections. At least 23,000 people die
each year as a direct result of these antibiotic-resistant infections. Many more die from other
conditions that were complicated by an antibiotic resistant infection.
Bacteria can acquire antibiotic resistance in twoways: i) internally by self spontaneous geneticmutation;
ii) externally by acquiring an antibiotic resistant gene from another bacterium. These two processes corre-
spond to the twoprimary fundamentalmechanismsof bacterial genomeevolution (via genomic plasticity):
i) spontaneous mutation of the microbes’ genome through external damage (e.g. chemical, radioactive) or
internal errors (e.g. faulty replicationor repairmechanisms), or ii) obtainingnovel genes externally through
horizontal gene transfer (HGT). Both mechanisms yield genetic novelty which, in turn, can enable novel
phenotypic functionality that may increase microbes’ fitness.
Bacterial genomeevolutionhasposedan increasing challenge forusdue to its implications inpathogenic-
ity [3, 4] and acquired antibiotic resistance [5, 6]. To provide a more thorough insight, this thesis presents
the development of novel experimental assays and mathematical models to quantify the physical parame-
ters and examine their eﬀects associated with these two fundamental mechanisms of bacterial evolution.
1.1 Evolution in theMicrobialWorld
The theory of evolution by means of natural selection describes the process of progeny with higher fitness
becomingmore common over generations, whereas the ones with lower fitness become less common. The
2
term “fitness”, in the language of population and evolutionary sense, describes the eﬀectiveness of organ-
isms to utilize resources in the environment to survive and reproduce [7]. Optimizing either survival or re-
production increases organisms’ opportunity to saturate the environment with individuals from their own
genetic background. Genetic novelty provides the raw material for this optimization process, and when
subjected to selective pressure, it then becomes the driving force for adaptation. Genetic novelty is only
useful to an organism’s fitness if the genes are both i) expressed by the organism (vs. junk DNA) and ii)
beneficial to the surviving under the selective condition.
Though a large body of theory addresses the kinetic and dynamic process leading to adaptation under
selection, laboratory testingof these theories in a controlledenvironment is onlymadepractical through the
study ofmicrobial populations. Due to their small size and short generation time, bacteria allowpopulation
studies on the laboratory scale (reviewed in [8, 9]).
Historically, thefirst intentional cultivationofmicrobial populationsbyhumans (other thanourpersonal
microbiomes) was probably fermentation. Quantitative work began in the mid-20th century, pioneered
by French biologist Jacques Monod [10] in batch cultures, and later extended to continuous cultures in
chemostats by Aaron Novick and Leó Szilárd [11] (after these two former Manhattan Project physicists
switched field from nuclear reactors to bio-reactors). Fermentors and bio-reactors are now commercially
available on the pilot (and industrial) scale and continue to increase in technological sophistication. These
platforms as well as repeated batch serial dilution techniques [12] have enabled growth and adaptation
experiments over 102 to 105 generations, allowing researchers to begin to quantify and model the driving
forces of bacterial evolution.
1.2 Horizontal GeneTransfer
In1928, BritishbacteriologistFrederickGriﬃthconducted thefirstwidely acceptedexperiments that started
the scientific pursuit to understand horizontal gene transfer (HGT). Griﬃth demonstrated that avirulent
3
bacteriumStreptococcus pneumoniae type III-S (smooth) strain can transform intovirulent type II-R(rough)
strain when the smooth strain is injected into mice together with heat-killed rough strain [13]. The nature
of Griﬃth’s transforming principle was finally decoded by one of the founding fathers of modern genetics
—Oswald Avery. In 1944, Avery, leading the Rockefeller University team that includes Maclyn McCarty
andColinMacleod, identified thepneumonia inducing gene transfered from the rough strain to the smooth
strain was carried by DNA, thus proved the carrier of genes is DNA instead of the prevailing believed pro-
tein [14]. Transformation — bacterial cells taking up exogenous DNA from surrounding environment
through cell membrane, is the first identified mechanisms of HGT.
Joshua Lederberg and his mentor Edward Tatum at Yale University in 1946 [15] discovered that bac-
terium Escherichia coli can exchange genetic information analogous to sexual reproduction. Conjugation
—DNAbeing transfered between bacterial cells through direct cell-to-cell contact or by a bridge like struc-
ture, is the secondmechanism of HGT. It has been shown conjugation can happen within a species as well
as between species, and even kingdoms [16, 17].
The third mechanism of HGT is transduction, which describes the transfer of one bacterium host ge-
nomicDNA to a new host by a virus upon infection. It was discovered again by Joshua Lederberg, together
with his graduate studentNorton Zinder in 1952. They demonstrated bacteriophage P22 can carry genetic
material from one strain of bacterium Salmonella typhimurium to another [18].
Driven by increasingly routine whole genome sequencing and partial sequencing of whole microbial
communities (metagenomics), subsequent comparative genomics studieshave revealed thatbacterial genome
plasticity in natural environments is extensive [19–21]. For prokaryotes, HGT facilitates genomic innova-
tion [19, 21, 22] and compensates for the lack of sexual recombination, providing potential adaptive and se-
lective advantage. Hence it is often referred to as “bacterial sex” [23]. HGT is facilitated throughmobile ge-
netic elements [24] including insertion sequences, transposons, integrons, genomic islands, and of partic-
ular interest to this work, plasmids and bacteriophage. These elements comprise the available pangenome
[25] for HGT in an ecological community.
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This thesiswill focusmainly on conjugation. Conjugationwas first observed in the gramnegative species
E. coli [15] and later in the gram positive species Streptococcus faecalis [26]. In gram positives, conjugation
is triggered by pheromones, secreted from the recipient to the donor, which activate the genes on the con-
jugative plasmid to induce cell aggregation (review [27]). Unlike phage transduction which is limited by
host-phage compatibility, conjugation is broad host compatible. Genomic evidence reveals DNA transfer
between genera, phyla and even major domains [16, 28].
Plasmids, a term coined by Joshua Lederberg in 1952 [29], are circular pieces of extra chromosomal
DNA which contain a replication origin to recruit to host polymerase for autonomous replication and
copy number maintenance [30]. Plasmids vary greatly in size (lengths of 1–1000 kbp) and function, of-
ten containing genes involved in detoxication, virulence, ecological interactions, antibiotic resistance, and
conjugation.
Conjugative plasmids [31] encode for the necessary component for mating pair formation and DNA
transfer and are a powerful tool for genome evolution as they can harbor and transfer genes between organ-
isms sampling all genomeswithin an ecosystem[32]. Conjugative plasmids are among the largest plasmids,
generally in the range of 15–750 kbp). Some conjugative genes have also been found on transposons [33]
though plasmid systems have been studied more extensively.
Numerous mechanisms are responsible for plasmidmobility. A recent analysis [34] of all publicly avail-
able plasmid sequences defined potential mobility by the presence of two elements, oriT (transfer origin)
and a mobilization relaxase gene. Mobile plasmids may also contain a type IV secretion system coupling
protein. However, for conjugation, the full type IV secretion system (T4SS) is required (recent reviews
of T4SS diversity, functionality, and evolution [35–39]). The general mechanism of conjugation is highly
conserved in both plasmids and transposon systems [39]. First theDNA substrate is processed by proteins
that assemble around the origin of transfer (oriT), forming a complex called the relaxome. The relaxome
complex then nicks and unwinds theDNA by binding to the 5’ end of the oriT region. TheDNA-relaxome
complex is then recruited to the T4SS channel by ATPase homologues and is translocated.
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Three types of T4SS have been described [39, 40]: i)mediators of conjugal DNA transfer between cells;
ii) eﬀector translocator systemswhichdeliver proteins or other eﬀectormolecules to eukaryotic target cells;
and iii) DNA release or uptake systems that translocate DNA to or from the extracellular domain. Both i)
and ii) are important pathways for pathogenic organisms, with i) being the basis for genetic plasticity and
ii)establishing host-pathogen interaction [41]. In the last ten years, considerable research has discovered
the role of T4SS secreted eﬀector molecules in the pathogenicity ofHelicobacter pylori, Bordetella pertussis,
Bartonella Spp. and the intracellular survival of Legionella pneumophila, Brucella spp. (reviewed in [4, 41]).
However, the overwhelming concern in many hospitals is the possibility for acquired antibiotic resistance
fromT4SS conjugal plasmid transfer in both gram negative and gram positive species, for instance, Entero-
coccus faecium a gram positive vancomycin resistant donor, and methicillin resistant Staphylococcus aureus,
which are rapidly acquiring vancomycin resistance [42, 43].
Cells containing the conjugative plasmid are referred to as donors, while the cells receiving the plasmid
are termed recipients. Followingmating pair formation, the conjugative plasmid is transferred to the recipi-
ent, thus enabling the recipient to become an active donor. Themating bridge also allows the two genomes
to participate in sexual recombination [15] as well as transferring any smaller non-conjugative plasmids
[44]. Like other plasmids, conjugative plasmids contain a replication origin (oriV), recruiting the host
polymerases to replicate, and thus propagate the plasmid to daughter cells through replication as well. This
muddles the boundary between proliferation and genetic exchange in prokaryotes [45].
1.3 SpontaneousMutation
Although HGT is more widely studied in microbial communities, within a single lineage under selective
pressure, spontaneous mutation can also be a powerful contributor by altering the sequence of DNA. Sal-
vado Luria and Max Delbrück identified that genes can be spontaneously mutated in their famous 1943
FluctuationTest experiment [46], and they were also the first to quantify the rate of spontaneousmutation
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in bacteria.
Mutations happened within gene exons or regulatory elements can confer observable eﬀects to organ-
ism’s phenotype. Most spontaneousmutations are neutral (having no eﬀect on the fitness of the organism)
or deleterious (decreasing the fitness of the organism), and advantageous mutations (increasing the fitness
of the organism) occur at a lesser frequency. The accumulation of spontaneous mutations can achieve an
appreciable eﬀect over a long period of time. For instance, sometimes pointmutations (in the genome) can
confer resistance to antibiotics, and long term (persistent) infections treated withmultiple antibiotics (pe-
riods of selective pressure) show accumulation of multiple resistant point mutations [47] simply through
their inherent mutagenesis rate and population size.
Mutation rate reflects the balance betweenmaintaining the fidelity ofDNA replication and the flexibility
of adapting to changing environments. Mutation rate varies across species. With regards to an organism’s
“optimized” inherentmutation rate, there is a strong inverse correlationwith genome size/complexity [48].
In E. coli, the spontaneous mutation occurs at a very low rate, which is less than 10−9 per base pair per
replication [49].
Compared to a wild-type phenotype with low spontaneous mutation rate, a mutator phenotype has a
much higher spontaneous mutation rate due to the defects in DNA replication/repair or protein transla-
tion systems [50, 51]. Of these systems, the methyl-directed mismatch-repair system (mutS, mutL, mutH
and uvrD) has been found to be the most frequently aﬀected in naturally mutator phenotypic bacterial
populations [52, 53].
Under constant environment conditions, the increased mutation rate reduces the relative fitness of the
mutator phenotype through the accumulation of deleteriousmutations [54], and the wild-type strain with
the lower mutation rate usually goes to fixation. However, in fluctuating conditions, analogous to “real”
environments, the mutator phenotype can confer a fitness advantage through the increased probability of
generating beneficial mutations. Adaptation occurs by introduction of a beneficial allele by mutation, and
then selection for that allele drives fixation. When beneficial mutations occur, modifier alleles that raise
7
the mutation rate (mutator phenotype) can hitchhike to high frequency with them, thereby increasing the
average mutation rate in the population [55–59].
In laboratory experiments, mutators can be selected and enriched for in conditions such as nutrient lim-
itation or antibiotic stress, becoming dominant. Surprisingly, even in natural environments, mutators can
sometimes represent as much as 15% of the population [52, 60–62]. They have gained renewed interest
due their prevalence in infectious disease [63–66] and implications towards cancer [67, 68].
Previous work in large experimental populations of bacteria has demonstrated that mutators can prolif-
erate in association with new beneficial mutations [69, 70] if above a certain inoculation threshold (den-
sity dependence). Below this threshold, mutators will typically decline in frequency because wild-type
are more likely to be associated with new beneficial mutations. However, when a large bacterial culture is
exposed tomultiple rounds of lethal selection, the frequency of clones bearing spontaneousmutatormuta-
tionswithin the culture canbegreatly enhancedbecause these cloneshave ahigher probability of producing
mutants that survive the selection [71]. Recent modeling using temporal fluctuations in selection [72, 73]
have found that even very small initial populations of mutators can become fixed.
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2
Conjugation
As much of our modern laboratory molecular biology and genetic engineering rely on the use of
plasmids, we still lack full understanding of plasmid dynamics to eliminate the uncontrolled spread of un-
desired genes through plasmid-based horizontal gene transfer. To understand the transfer, maintenance
and loss of plasmids, numerous interesting mathematical models [74–81] to describe plasmid conjuga-
tion have been developed over the past decade, where the experimental validation relied on quantifying
the number of functional transconjugants through selective culturing. This strategy has at least two short-
comings: selective culturing introduces the contribution of selection pressure and fitness; it is diﬃcult to
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parse the transfer rate of the plasmid from the additional mechanistic steps involved in the formation of
functional transconjugants. A clever alternative to selective culturing is the use of donor-suppressed fluo-
rescent reporter genes [82, 83], which upon transfer, create fluorescent recipients. Although reporter genes
like green fluorescent protein are functional in a broad number of species, the production of nonessential
proteins can also be a metabolic burden, again creating a selection pressure.
Toovercome theseproblems, this chapterpresents anovel quantitativepolymerase chain reaction(qPCR)
assay to directly measure the plasmid transfer through the relative abundance of carefully chosen genetic
loci. This method not only improves the reproducibility and signal-to-noise level through qPCR’s single
molecule (loci target) sensitivity, but also avoids adding selective factors by eliminating measurement’s
dependence on culturing.
I will first demonstrate the eﬀectiveness of using qPCR to track the growth of diﬀerent genetic markers
(loci) within a homogeneous (clonal) population in real time in a batch culture. Unlike the bio-reactor
continuous culture experiments, the batch culture is a natural limitation to impose a resource constraint
resembling “real” environment.
I will then extend the study to a population of cells with an inhomogeneous initial distribution of a ge-
netic marker which can be exchanged between a donor and a recipient bacterium. In themodel bacterium,
Escherichia coli, this process is enabled by a series of genes encoded on an independently replicating mini-
chromosome called the F plasmid [29]. Conjugation commences when the tips of F pili from a donor
cell (termed F+) make contact with recipient cells (F-) [31, 32] creating a mating bridge. Recent work
has shown the pili to be a dynamic structure, extending and retracting continuously [84]. When the pili
retract, the cells form a mating pair aggregate [85]. Though the process of conjugation in E.coli has been
studied since the 1950s, all prior experiments required selective culturing prior to enumeration. Our qPCR
method does not require selective culturing, thus enabling the study of bacterial conjugation process in the
absence of selective pressure.
I initially hoped to investigate this model conjugation system in both positive and negative selection
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conditions. Ironically, I found that the rate of conjugation was comparable to the encounter rate of bacteria
(see Section 2.4). Hence, it was impossible to expand the study tomeasure the influence on the kinetics of a
positive selective force (e.g. acquired antibiotic resistance). However, themaintenanceof “sexuality” comes
at ametabolic cost to the bacterium aswell asmaking the cell venerable to viral attacks. Bacterial viruses, or
bacteriophage, are specific to the conjugation machinery, infiltrating the cell and hijacking the metabolism
for replication of viral particles. Therefore, it is surprising that the genes enabling conjugation persist in the
environment if they are not conferring a benefit above those costs of maintaining the conjugative genes.
I will once again use the qPCR assay to elucidate the kinetic influence of a filamentous phage specific to
the conjugation machinery, M13, on the growth of the host cell. Filamentous phage do not kill their host,
and the infected cells continue to grow and divide indefinitely while producing new phage particles. M13
phage do not form in the cytoplasm; rather they are continually extruded or secreted across the bacterial
membranes as they are assembled, without causing cell lysis [86]. SinceM13 phage do not lyse the host, it
has become a popular model system for studying chronic infection.
Finally, I will investigate howM13 phage infection aﬀects the dynamics of plasmid conjugation between
donor (F+) and recipient (F-) cells. By quantifying phage’s impact on conjugation, one can derive a regime
in which phage therapy could be a viable option to treat the spread of antibiotic resistance through plasmid
conjugation.
2.1 Materials andMethods
2.1.1 Strains
E. coli strainW6 (F+, relA1, spoT1,metB1, rrnB-2, creC510)(CGSC4427)was used as donor in conjugation
experiment. For recipient, aW6 (F-) strainwas created by curingW6 (F+)with amodified acridine orange
protocol: W6 (F+) cells were grown overnight in Luria broth supplemented with 80 µgmL−1 acridine or-
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ange at 37 °C (details in [87, 88]). The loss of F plasmid was confirmed by the loss of traI qPCR signal (see
Section 2.1.3). Following curing, an essential F plasmid replication gene rpoH was sequenced to assure the
absence of unintended secondary mutations.
TheM13bacteriophage (ATCC15669-B1)were revivedbefore eachgrowthexperiment (seeSection2.1.2
for phage revival details).
2.1.2 Growth Assays
The growth assays diﬀered based on the four tested conditions: 1) pure culture growth; 2) conjugation;
3) phage infection; 4) conjugation under phage infection. I have chosen conditions of each growth experi-
ment to measure selected mathematical model parameters, thus reducing the number of unknown param-
eters in the final complete model (see Section 2.2 for details of the model).
Single colonies ofW6 (F+) andW6 (F-) cells were inoculated into separate glass tubes containing 5mL
Luria broth, and grew at 37 °C overnight.
M13 phage were revived by mixing with exponential growth phase W6 (F+) cells in 3mL Luria broth
and allowed to grow overnight at 37 °C. 1mL of the overnight culture was centrifuged at 12 000 rpm for
10min (Eppendorf Centrifuge 5417R; Eppendorf AG, Hamburg, Germany). The fresh supernatant con-
taining the revivedM13phagewas collected for growth experiment. It has longbeenunderstood that phage
infection inhibits the growth ofE.coli cells, hence it is possible to visualize translucent phage plaques against
a saturated E. coli lawn in top agar. Prior to each growth experiment, the phage were titered on W6 (F+)
lawns to quantify the viable concentration used in each experiment.
Common to all tested conditions, inoculum subcultures of pure ormixed cell populationswere prepared
in a 1.7mL tube, then the volume specified in each condition was used inoculating 50mL preheated 37 °C
Luria broth in 250mL flasks.
Condition 1) pure culture growth: The overnight W6 (F+) cultures was used as inoculum.
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Condition 2) conjugation: TheovernightW6(F+) andW6(F-) culturesweremixed in ratios of F+:F-
(1:1(500 µL:500 µL), 1:10(100 µL:1000 µL), 1:102(10 µL:1000 µL), 1:103(1 µL:1000 µL)). 200 µLof each
mixture was then used as inoculum.
Condition 3a) phage infection—varying cell inoculum concentration: 500 µLof ten-fold serial di-
lutions (1, 10−1 and 10−2)were prepared from overnight W6 (F+) culture. Each serial dilution was then
mixed with 5 µL freshly revived M13 phage (titer 1011mL−1). The full volume of the mixture (505 µL
was then used as inoculum.
Condition 3b) phage infection—varying phage inoculum concentration: Ten-fold serial dilutions
were prepared from freshly revived phage supernatant (1, 10−1, 10−2, 10−3 and 10−4). 50 µL of each phage
dilution was mixed with 50 µL W6 (F+) cells, and the full volume of the mixture (100 µL) was used as
inoculum.
Condition 4) conjugation under phage infection: W6 (F+) andW6 (F-)mixtures of diﬀerent ratios
were prepared by following condition 2). 200 µL of each mixture was then used as inoculum. Right after
inoculation of cell mixtures, each flask was inoculated with 5 µL freshly revived M13 phage culture (titer
1011mL−1).
Flasks were then incubated in a water bath immersion shaker (model G67; New Brunswick Scientific,
New Brunswick, NJ), shaking at 110 rpm, and maintained at 37 °C. The rate of mating pair formation has
been shown to be constant over a broad range of shake flask shear forces (0 to 300 rpm) [81]. 100 µL
aliquots were extracted every 15 or 20min without pausing the shaking or removing the flask from the
immersion bath. The 100 µL aliquot was diluted with 400 µL water (Millipore - MilliQ RO purified), then
placed in a 95 °Cdry bath to lyse the cells (preserving the cell number anddenaturing potential degradation
enzymes). Aliquots were then stored at −20 °C until their use as template for the qPCR assays.
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2.1.3 Quantitative PCRAssay
Quantitative PCR is routinely used for quantifying targeted DNA abundance. It allows for the enumera-
tion of a targeted genetic marker (DNA or RNA) at unrivaled sensitivity (single copy number) through
optimization.
All qPCR reactions used amaster mix consisting of the following: 2mMMgCl2, 200 µM of each dNTP,
1U (per 25 µL volume) Roche FastStart Enzyme blend (Roche Diagnostics, Mannheim, Germany), 1X
Roche FastStartBuﬀer (Roche Diagnostics), 0.4 µM forward and reverse primers (see Table 2.1 for primer
details), 2 µM SYTO 9 green fluorescent nucleic acid stain (Invitrogen; Life Technologies, Carlsbad, Cal-
ifornia), and 1X ROX reference dye (Invitrogen; Life Technologies). Instead of more widely used SYBR
Green dye, SYTO 9 dye is used for double stranded DNA quantification as it has been shown to have less
sequence and concentration artifacts [89]. 5 µL lysed frozen aliquots from growth experiments were used
as template for a 25 µL qPCR reaction.
All reactions were performed in a BioRad Chromo4 Instrument (Bio-Rad Laboratories, Hercules, CA),
in 96 well, clear bottom, hard shell, skirted assay plates (Bio-Rad Laboratories) with Microseal B sealing
tape (Bio-Rad Laboratories). The instrument filter was set to FAM for SYTO9. When ROX was used as a
passive reference dye, additional filter ROX was also set. Thermal cycles used are following: one cycle of
95 °C for 6min, followed by 35 cycles of 95 °C for 30 s, 50 °C for 30 s, plate read, and 72 °C for 25 s.
Table 2.1: Primers used in conjugation study
Primers 50 ! 30
tolC Forward CGACAAACCACAGCCGGTTA
tolC Reverse CAGCGAGAAGCTCAGGCCA
traI Forward GCCATTCATCTTGCCCTTCC
traI Reverse GCATGACCGCCTCCTTACC
M13 Forward TTGTTCCTTTCTATTCTCACTCC
M13 Reverse CACCCTCAGAACCGCCACC
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Figure 2.1: (a) Log plot of the fluorescent signal of amplification curves from 24 qPCR reactions. The threshold
cycle (Ct) of a specific reaction is the cycle number at which the of the amplification curve intersects the thresh-
old line. The red amplification curve show one example of determine Ct of that specific reaction. (b)The Ct
value is inversely related to the amount of starting template. A plot of the Ct values versus time yields the growth
curve for the targeted locus. The red circle corresponds to the red amplification curve of subplot a
Figure 2.1a shows the output of a qPCR growth assay. The fluorescent signal of amplification curves is
proportional to the amount of double strandedDNA(dsDNA)product. The relative abundance of starting
template can be quantified by the time elapsed for the amplification curve to intersect with the florescent
signal threshold (labeled as threshold in Figure 2.1a). Usually the threshold is chosen to intersect amplifi-
cation curves during exponential phase (linear phase in Figure 2.1a because the fluorescence is plotted in
log scale). As the cell population grows, the number of targeted locus DNA grows proportionally. There-
fore samples collected at later time points should have larger amount of template DNA compared to those
collected at early timer points. As the amount of starting template DNA increases, the time necessary to
reach the threshold value decreases. The threshold values, Ct, can be translated into a growth curve (Fig-
ure 2.1b) by plotting the Ct value of each amplification curve from Figure 2.1a versus its corresponding
sample collecting time point.
The starting template DNA concentration, n, can be converted to Ct values as following:
Ct = Ct0   log2 n (2.1)
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where Ct0 is an arbitrary constant determined by best fitting qPCR data. The single copy chromosomal
gene tolCwas found in both plasmid-bearing (F+) and plasmid-free (F-) cells, but the single copy plasmid
gene traI was only found in the plasmid-bearing (F+) cells. Therefore Ct(tolC) should correspond to the
total number of F+ and F- cells, whileCt(traI) should only correspond to the number of F+ cells. Another
single copy gene was chosen to track M13 phage, and Ct(M13) should correspond to the number of M13
phage particles.
Ct(tolC) = Ct0   log2(nF+ + nF-) (2.2)
Ct(traI) = Ct0   log2(nF+) (2.3)
Ct(M13) = Ct0   log2(nM13) (2.4)
where nF+; nF- and nM13 represent the number of F+ cells, F- cells andM13 phage respectively.
One can see from Figure 2.2, the error in duplicate qPCR reactions using the same template (frozen cell
aliquots from a single growth assay) is less than one cycle, including the error in the saturated phase. This
means the error of qPCR is less than two fold, which is much more accurate compared to traditional plate
colony counting technique.
2.2 MathematicalModel
Our resource-limited mass-action model was based on a series of papers that Bruce Levin and colleagues
developed to study the dynamics of conjugation and the eﬀect of M13 phage infection on conjugation
process[90–93].
During conjugation, recipient cells (R) receive a copy of plasmid from donor cells (D) and become
transconjugant cells (T), whereas donor cells become temporarily exhausted donor cells (X). The delays
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Figure 2.2: Circles and squares represent duplicate qPCR reactions using the same frozen cell aliquots of a sin-
gle growth assay time series. As one can see the diﬀerence between duplicate qPCR reactions is less than one
cycle
in transconjugant cells and temporarily exhausted donor cells becoming active donor cells are 1=λT and
1=λX respectively.
The interaction kinetics becomes more complex with the addition of phage. As M13 phage (P) is a F+
specific phage, because it can only infect plasmid-bearing donor cells (D) by binding to the tips of F+ cells’
pili. Newly infected cells (N) cannot produce phage immediately, hence I introduce a lag time of 1=λN to
account for the delay in becoming active phage-producing infected cells(I).
WhenM13 phage (P) are introduced into a mixture of donor (D) and recipient (R) cells, there is com-
petition between conjugation and phage infection. Infected cells (N) can still conjugate, and become tem-
porarily exhausted infected cells (XI), assuming they have the same lag time of 1=λX as uninfected cells to
be able to conjugate again.
A schematic of phage and cells’ various states, including all transition pathways, are shown in Figure 2.3.
For easy reference, all symbols used in conjugation model are summarized in Table 2.2. The dynamics
of resource consumption and each cellular state can be described by the following ordinary diﬀerential
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Figure 2.3: Schematic of all allowed transitions between cellular states during conjugation under phage infec-
tion used in the mathematical model. Each node represents a cellular state with its abbreviation in the node
center followed by + or - representing plasmid-bearing and plasmid-free respectively. Black arrows denote the
transitions between cellular states with specified transition rates. Black dashed arrows denote phage production
and infection. Red dashed two-way arrows point to celluar states where conjugation happens
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Table 2.2: Symbols used in conjugation model
Symbols Physical Quantity
nD Density of donor cells (F+)
nR Density of recipient cells (F-)
nX Density of exhausted donor cells (F+)
nT Density of transconjugant cells (F+)
nN Density of newly infected cells (F+)
nI Density of infected cells (F+)
nXI Density of exhausted infected donor cells (F+)
nP Density of M13 phage
n Density of all cells n = nD + nR + nX + nT + nN + nI + nXI
r Resource concentration
e Resource consumption per cell division
Q Concentration of resource when rate is half-maximum
K Cell carrying capacity
KP Phage carrying capacity
ψ(r) Resource-dependent cell growth rate
γ(r) Resource-dependent conjugation rate
β(r) Resource-dependent phage infection rate
ψP(r) Resource-dependent phage production rate
ψMAX Maximum cell growth rate
γMAX Maximum conjugation rate
βMAX Maximum phage infection rate
ψPMAX Maximum phage production rate
1=λT Delay time in transconjugant cells becoming donor cells
1=λX Delay time in (infected) exhausted donor cells becoming (infected) donor cells
1=λN Delay time in newly infected cells becoming phage-producing infected cells
Pψ Penalty factor of cell growth rate due to phage infection
Pγ Penalty factor of conjugation rate due to phage infection
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equations:
dr
dt
=  eψ(r)(nD + nR + nT + nX)(1  nK)  ePψψ(r)(nN + nI + nXI)(1 
n
K
) (2.5)
dnD
dt
= ψ(r)nD(1  nK)  γ(r)nDnR + λXnX + λTnT   β(r)nDnP (2.6)
dnR
dt
= ψ(r)nR(1  nK)  γ(r)nDnR   Pγγ(r)nInR (2.7)
dnT
dt
= ψ(r)nT(1  nK) + γ(r)nDnR   λTnT + Pγγ(r)nInR (2.8)
dnX
dt
= ψ(r)nX(1  nK) + γ(r)nDnR   λXnX (2.9)
dnN
dt
= Pψψ(r)nN(1  nK) + β(r)nDnP   λNnN (2.10)
dnI
dt
= Pψψ(r)nI(1  nK) + λNnN   Pγγ(r)nInR + λXnXI (2.11)
dnXI
dt
= Pψψ(r)nXI(1  nK) + Pγγ(r)nInR   λXnXI (2.12)
dnP
dt
= ψP(r)(nI + nXI)(1 
nP
KP
) (2.13)
Equation(2.5)describes the rateof all cellular states (nodes inFigure2.1) consuming resource r through-
out growth until saturation. In resource-limited batch culture growth, cells follow logistic growth charac-
terized by the term 1   nK , in which n is the total cell density and K is the cell carrying capacity. Cells stop
multiplying when resource is depleted or cell carrying capacity is reached. The cell growth rate is repre-
sented by ψ(r)while Pψrepresents the growth penalty of phage infected cells. Both infected and uninfected
cells utilize resource at the rate of e per cell division. Uninfected cellular states are described by their respec-
tive density: donors, nD, recipients, nR, transconjugants, nT, and exhausted donors, nX. Only functional
donors can be infected by M13 (represented by the arrow from D+ to N+), and the related infected states
are described also by their respective density: newly infected cells, nN, infected cells, nI, exhausted infected
donor cells, nXI, and phage, nP.
Equations (2.6) to (2.12) describe the growth of all cellular states. All growth rates also have to take tran-
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sitions between diﬀerent cellular states into consideration. There are two kinds of transitions represented
by first order and second order terms. First order terms represent the transition between inactive and ac-
tive conjugation and phage production states, and the associated rate constants: λT; λX and λN , which are
resource independent. Their reciprocals can be interpreted as delay time in transconjugant cells becoming
donor cells, (infected) exhausted donor cells becoming (infected) donor cells, and newly infected cells be-
coming phage-producing infected cells respectively. Second order terms represent conjugation and phage
infection, and the associated rate constants γ(r) and β(r) are resource dependent. Pγ represent the penalty
factor of conjugation rate due to phage infection.
Equation (2.13) describes the phage production of infected cells. It follows a similar form of cell growth
with resource-dependent production rate of ψP(r), and phage carrying capacity of KP.
Jacques Monod proposed that bacterial growth kinetics resemble enzyme kinetics in terms of substrate
limitation [94], an idea that was further refined for modeling conjugative transfer as a Michaelis-Menten
kinetic scheme [74]. Similarly one can assume the cell growth rate ψ(r), conjugation rate γ(r), phage in-
fection rate β(r) and phage production rate ψP(r) all follow a hyperbolic form similar toMichaelis–Menten
kinetics in terms of resource concentration:
ψ(r) =
rψMAX
Q+ r
(2.14)
γ(r) =
rγMAX
Q+ r
(2.15)
β(r) =
rβMAX
Q+ r
(2.16)
ψP(r) =
rψPMAX
Q+ r
(2.17)
where the subscriptMAX denotes the rate maximum, andQ denotes the resource concentration when the
rate is half-maximum.
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2.3 Results
All simulations were performed using MATLAB. During simulation, Equations (2.5) to (2.13) were sim-
plified according to growth assay conditions, and parameters values were optimized relying on themethod
of least squares regression.
2.3.1 Pure CultureGrowth
For growth assay Condition 1) pure culture growth, Equations (2.5) to (2.6) can be simplified as
dr
dt
=  eψ(r)nD(1  nK) (2.18)
dnD
dt
= ψ(r)nD(1  nK) (2.19)
Carrying capacityK
I estimated the order of magnitude for the carrying capacity, K , in Luria broth by counting the number of
cells at saturation using a hemocytometer. The estimated K  109mL−1 value has been cross validated by
counting viable colony on Luria broth plates. The estimated value was used as initial value for least squares
regression. The optimization yielded the value of carrying capacity in Luria broth K = 3.5 109mL−1.
Maximum growth rate ψMAX
To extract the maximum growth rate, by following growth assay Condition 1), a pure culture of F+ cells
was grown and the time series samples were tested for the abundance of tolC and traI loci. Mating between
F+ cells is unlikely due to surface exclusionmechanisms encoded by traS and traT genes [95]. It was found
the growth (Figure 2.4) of the tolC (circle) and traI (square) lociweremaintained at a ratio of approximately
1:1 throughout the batch growth process, consistent with the previous observations of one F plasmid per
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Figure 2.4: Time series plot of tolC (circle) and traI (square) for a pure F+ culture. Red line represents the fitted
curve
cell. Hence, one can infer that cellular replication is the underlying mechanism increasing the abundance
of both loci. The maximum growth rate, ψMAX = 0.035min−1 can be extracted from Figure 2.4 by fitting
the exponential phase.
Resource consumption per cell division e and resource concentrationwhen rate is half-maximumQ
Since r scaleswith e (Equation (2.5)), bothparametersweredefined in termsof arbitraryunits (a.u.). Again,
the growth of pure F+ culture (Figure 2.4) was used for these estimates. Equation (2.14) relatesQ = 1 a.u.
and r = 100 a.u. to the maximum growth rate ψMAX = 0.035min−1. Using Equation (2.5) under these
constraints enables us to find e = 3.5 10−8 a.u. mL. Values of e have been reported for defined glucose
supplementedminimalmedia [93]. However, Luria broth, the common laboratorymedia for rapid growth
ofE. coli cultures, is not supplementedwith glucose. Growthhas been shown tobe limited by the utilization
of catabolizable amino acids [96].
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Figure 2.5: Simulation (solid red line) and qPCR data (symbols) of time series plots of tolC (a) and traI (b) for
conjugation between F+ and F- cells. Each plot represents a diﬀerent inoculation ratio of F+ to F- cells: pure
F+ (donor) culture (downward-pointing triangle)(same as Figure 2.4), 1:1 (upward-pointing triangle), 1:10
(diamond), 1:102 (square), and 1:103 (circle)
2.3.2 Conjugation
For the growth assay Condition 2) conjugation, Equations (2.5) to (2.9) can be simplified as
dr
dt
=  eψ(r)(nD + nR + nT + nX)(1  nK) (2.20)
dnD
dt
= ψ(r)nD(1  nK)  γ(r)nDnR + λXnX + λTnT (2.21)
dnR
dt
= ψ(r)nR(1  nK)  γ(r)nDnR (2.22)
dnT
dt
= ψ(r)nT(1  nK) + γ(r)nDnR   λTnT (2.23)
dnX
dt
= ψ(r)nX(1  nK) + γ(r)nDnR   λXnX (2.24)
Maximum conjugation rate γMAX
Figure 2.5 shows the time series of tolC (Figure 2.5a) and traI (Figure 2.5b) loci in conjugation experiments
described in growth assay Condition 2). Each plot represent a specific ratio of F+ to F-: 1:1 (upward-
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pointing triangle), 1:10 (diamond), 1:102 (square), and 1:103 (circle). For comparison, the pure F+ culture
data (from Figure 2.4) is also shown in Figure 2.5 as downward-pointing triangles.
One can easily observe the rate of growth for the chromosomal tolC loci (Figure 2.5a) is similar across
all mixtures as well as the pure F+ culture. However when examining the rate of growth of the plasmid traI
loci (Figure 2.5b), the exponential phases all diﬀer from the growth of the pure F+ culture, reflecting the
contribution of conjugation events.
The solid red lines shown are plots of simulation results. I allowed the least squares algorithm to search
for the best values, starting fromour estimates ofK; ψMAX; e andQ fromabove discussions and the reported
values for λT and λX [74, 97]. I found the maximum plasmid transfer rate in uninfected cells to be γMAX =
3 10−10mLmin−1.
2.3.3 Phage Infection
For the growth assayCondition 3) phage infection, Equations (2.5), (2.6), (2.10), (2.11) and (2.13) can
be simplified as
dr
dt
=  eψ(r)nD(1  nK)  ePψψ(r)(nN + nI)(1 
n
K
) (2.25)
dnD
dt
= ψ(r)nD(1  nK)  β(r)nDnP (2.26)
dnN
dt
= Pψψ(r)nN(1  nK) + β(r)nDnP   λNnN (2.27)
dnI
dt
= Pψψ(r)nI(1  nK) + λNnN (2.28)
dnP
dt
= ψP(r)nI(1 
nP
KP
) (2.29)
Phage carrying capacityKP
As mentioned in growth assay, a standard plaque assay was used to estimate the phage carrying capacity.
At the beginning of each growth experiment, phage were also titered on W6 (F+) lawns to quantify the
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Figure 2.6: (a) Diﬀerent concentrations of cells (tolC locus (solid red line)) infected by the same concentra-
tion of phage (red dotted line) at ratio of 1:1 (downward-pointing triangle), 10−1:1 (upward-pointing triangle),
10−2:1 (diamond). (b)The same concentration of cells (tolC locus (solid red line)) infected by diﬀerent con-
centrations of phage (red dotted line) at ratio of 1:102 (downward-pointing triangle), 1:10 (upward-pointing
triangle), 1:1 (diamond), 1:10−1 (square), and 1:10−2 (circle)
viable concentration used in each experiment. The values from various experiments gave the estimation of
KP  1011mL−1 was used as the initial parameter value for following least square optimization. The final
optimized value is KP = 4 1011mL−1.
Maximumphage infection rate βMAX, maximumphage production rate ψPMAX and penalty factor of
cell growth rate due to phage infection Pψ
To assess the phage infection rate and production rate, pure F+ cultures were inoculated with M13 with
two diﬀerent experimental conditions to extract phage related parameters. Figure 2.6a shows the result of
growth assayCondition3a)with diﬀerent cell inoculum concentrations (1 (downward-pointing triangle),
10−1 (upward-pointing triangle), 10−2 (diamond)). Figure 2.6b shows the result of growth assay Condi-
tion 3b) with diﬀerent phage inoculum concentrations(1 (downward-pointing triangle), 10−1 (upward-
pointing triangle), 10−2 (diamond), 10−3 (square), and 10−4 (circle)).
To find the growth penalty factor Pψ , the tolC locus data from Figure 2.6 can be fitted with the adjusted
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growth rate Pψψ(r) , revealing a value pψ = 0.6 . This implies that infection reduces the maximum growth
rate to 60% of its original value.
Newly infected cells have a latent period of 30minutes before they begin to excrete phage [98], and this
value was used in this model. From Equation (2.13) one can see phage are produced at rate of ψP(r) per
infected cell. Fitting the data from Figure 2.6 yields maximum phage production rate ψPMAX = 6min−1 by
each infected cell. F+ donor cells are infected at a rate of β(r)nDnP as stated in Equation (2.6). Using all the
previously fixed values, one can again fit the phage data (red dotted line) in Figure 2.6 to find themaximum
phage infection rate βMAX = 3 10−11mLmin−1.
2.3.4 Conjugation under Phage Infection
For growth assay Condition 4) conjugation under phage infection, the complete mathematical model
of Equations (2.5) to (2.13) has to be used.
Penalty factor of conjugation rate due to phage infection Pγ
Finally, to test the eﬀect of phage infection on conjugation, growth assay Condition 4) was carried out
and the resulting growth data are shown in Figure 2.7. Figure 2.7a displays the chromosomal tolC locus,
Figure 2.7b the F plasmid traI locus, and Figure 2.7c the M13 phage. Simulations are shown as solid lines
through the data points. The contributions to each node in the mathematical model are now much more
complex, with every node and transition in Figure 2.3 represented. By using parameters found from the
previous growth assay Condition 1) to 3) in the complete model (Equations (2.5) to (2.13)) to fit the
penalty factor associated with the inhibition of conjugation, yields Pγ = 0.1, meaning the conjugation rate
is reduced to 10% of its maximum rate . This value is smaller but comparable to the reported value that
finds the average rate reduced by 5 fold [99]. However, unlike the good fits to the previously presented
data, there is a strong deviation from the model for phage production in Figure 2.7c at later time points.
27
0 100 200 300 400 500 600
5
10
15
20
25
30
35
Time (min)
Ct
a
0 100 200 300 400 500 600
5
10
15
20
25
30
35
Time (min)
Ct
b
0 100 200 300 400 500 600
5
10
15
20
25
30
35
Time (min)
Ct
c
Figure 2.7: (a)tolC, (b)traI and (c)M13 simulation (red solid line) and qPCR data (closed symbol) of conju-
gation under phage infection time series. Each plot represents a diﬀerent inoculation ratio of F+ to F- cells: pure
F+ (downward-pointing triangle), 1:1 (upward-pointing triangle), 1:10 (diamond), 1:102(square), and 1:103
(circle)
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Themodel appears to be in good agreement for large initial F+ concentrations but deviates when the F+:F-
ratio is 1:102 or below.
2.4 Discussion
This chapter presented a novel method to measure the population abundance of mixed cultures by enu-
merating the temporal growth of individual genetic loci in a qPCR assay. By separating measuring from
culturing, I reduced the error associatedwith selective culture screening. By lysing all samples immediately
after collection, I also greatly reduced the sampling error. By relying on the precision of qPCR, I obtained
highquality data for accurate downstreammodeling and simulation. Parameters used in conjugationmodel
simulation are summarized in Table 2.3.
Table 2.3: Parameter values used in conjugation model
Physical Quantity Value
r 100 a.u.
e 3.5 10−8 a.u. mL
Q 1 a.u.
K 3.5 109mL−1
KP 4 1011mL−1
ψMAX 0.035min−1
γMAX 3 10−10mLmin−1
βMAX 3 10−11mLmin−1
ψPMAX 6min−1
λT 1/90min−1
λX 1/30min−1
λN 1/30min−1
Pψ 0.6
Pγ 0.1
In terms of the plausibility of the maximum conjugation rate, the estimated value can be compared with
previous reported values on two levels. On population level, the best fit value γMAX = 3 10−10mLmin−1
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is not only in agreementwith previous estimates [92, 100–102] of the bulk conjugation rates found through
functional transconjugant enumeration (10−8 to 10−15mLmin−1), but also it fits experiments over a broad
range of F+ to F- ratios (from 1:1 to 1:103). On individual donor level, γMAX has to be converted to the
maximum conjugation rate per donor first. In this experiment, donor concentrations vary from 106 to
109mL−1, hence the corresponding conjugation rate per donor varies from 0.5 10−3 to 0.5min−1. The
upper limit is consistent with previous estimates of 0.15min−1 [74] and 0.25min−1 [103].
In terms of the reliability of themaximum conjugation rate, the estimated value leads to simulations that
agree well with the growth data generated from a large range of initial donor to recipient concentration
ratios.
This plausible and reliable estimated value also has one obvious advantage compared to the estimates
through other methods like selective culturing or fluorescence labeling. Estimates from these other meth-
ods encompass two distinctive steps: the actual conjugation step that starts from donor recipient encoun-
tering and ends with transfer of plasmid; the functional transconjugants formation step that requires recip-
ient to transcribe and translate the antibiotic resistance gene or fluorescence protein encoding gene from
newly acquired plasmid. As one can see already, the second step causes these estimated values to depend
on the choice of selective or fluorescence markers. Because this measurement bypasses the the additional
mechanistic step of functional transconjugants formation, the estimatedmaximumconjugation valuemore
accurately represents the fundamental process of conjugation—the transfer of genetic information through
the medium of plasmid.
To understand the physical significance of γMAX, notice the term representing the number of conjuga-
tions per unit time per unit volume γ(r)nDnR in Equations (2.6) to (2.9), is analogous to the number of
encounters per unit time per unit volume for two kinds of spherical particles in liquids. The encounter rate
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of two kinds of molecules A and B of identical radius due to diﬀusion is [103]
8kBTK
3η
nAnB = snAnB (2.30)
where kB is the Boltzmann constant (1.38 10−23 J K−1),TK is temperature (310 K (37 °C)), η is viscosity
of the liquid (1mPa s), nA and nB are the concentrations of particles A and B respectively. Using these
values, I found the search rate to be
s = 8 1:38 10
 23  310
3 1 10 3 = 1:14 10
 17m3s 1 = 6:84 10 10mLmin 1 (2.31)
which is the sameorderofmagnitudeas the valueof themaximumconjugation rate γMAX =3 10−10mLmin−1.
This suggests thatmost encounters result in plasmid transfer: conjugation is operating at an eﬃciency level
close to physical limits.
In terms of the phage results, the 40% reduction in growth rate is in good agreement with a recent works
[99, 104]. I found the maximum phage production rate of an infected cell of ψPMAX = 6min−1 is also in
agreement with the recently reported values of 1min−1 [99] and the historical work reporting 2min−1
[105, 106].
Finally, to put the maximum phage infection rate βMAX = 3 10−11mLmin−1 in perspective, note the
order of magnitude is very similar to the encounter rate and γMAX discussed above. To understand the
competitionbetweenconjugation andphage infection (F- cell andM13phage compete for thepili of theF+
cell), I can compare the conjugation frequency to phage infection frequency at the onset of mixing. In our
model, the encounter of donor F+ and recipient F- cells results in the conjugation frequency of γ(r)nDnR,
whereas the encounter of donor F+ cells andM13 phage leads to the infection frequency of β(r)nDnP. The
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Figure 2.8: Black solid lines represent F+ cell frequency during conjugation without phage, and red dashed
lines represent F+ cell frequency during conjugation with phage infection. Each pair of lines from top to bot-
tom represent a diﬀerent inoculation ratio of F+ to F- cells: 1:1, 1:10, 1:102, and 1:103. The diﬀerence between
these two represents the eﬀect of inhibition of conjugation due to M13 phage (a) Within the regime of inocu-
lum concentrations of F- cells andM13 phage 0:1, the eﬀect of phage infection has a small but observable
eﬀect on conjugation dynamics.(b) When the inoculum concentrations of F- cells andM13 phage 0:001, the
final F+ cell frequencies see a sharp decrease with M13 phage. For ratios of F+ to F- cells 1:102 and 1:103, con-
jugation is totally inhibited. Parameters used in the simulation are the same as Table 2.3. Initial conditions for
the four diﬀerent starting ratios: F+ cells 0.5 106, 105, 104 and 103; F- cells 0.5 106, 106, 106 and 106; M13
(a)1.5 107 (b)1.5 109
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ratio of conjugation frequency to phage infection frequency is
γ(r)nDnR
β(r)nDnP
=
γMAXnR
βMAXnP
(2.32)
From estimated values of parameters, γMAX=βMAX = 10, with a population diﬀerence of F- cells toM13
phage of nR=nP  0:1 upon inoculation. Hence a F+ cell has a similar probability of encountering a F-
and conjugating as being infected by a M13 phage. This contributes to the small diﬀerence of the trends
of F+ cells between conditions of without M13 phage (Figure 2.5b) and with M13 phage (Figure 2.7b).
Comparing the simulation results of the F+ cell frequency versus time for both conditions (Figure 2.8a),
it also confirms within the regime of my experiment, M13 phage only has a small eﬀect on conjugation.
Equation (2.19) predicts that the use of phage to regulate the conjugative spread of antibiotic resistance
markers requires a regime where nR  nP by several orders of magnitude. Recent kinetic studies [99]
indeed showed nR=nP  0:001 is suﬃcient for total inhibition of conjugation, and simulation using this
condition yields the same conclusion (Figure 2.8b).
33
3
Mutators
The majority of spontaneous mutations are neutral or deleterious, and only a small number of
them are beneficial. Organisms have evolved lower spontaneousmutation rates throughDNAproofread-
ing and repairing system that ensures the fidelity of DNA replication. Increasing the spontaneousmutation
rate of a cell should in general decrease its fitness due to accumulation of deleterious mutations.
The mutator phenotype exhibits elevated spontaneous mutation rate, and the accumulated deleterious
mutations will in turn, lower mutator phenotype’s fitness comparing to its wild-type counterpart. Thus,
in theory, a mutator phenotype should be scarce in nature, if it even exists. Contrary to this plausible rea-
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soning, themutator phenotype has been observed in natural thEscherichia coli (E. coli) and othermicrobial
populations [52, 60–62, 107, 108]. And the frequency of the mutator phenotype is even higher among
isolates from clinical environment [63, 109, 110].
Oneof themajor causesofmutatorphenotype, especially amongclinical isolates, results fromthegenetic
alternation of DNA mismatch repair system (MMR). MMR related genes (mutS, mutL, mutH, uvrD and
dam) are responsible for proofreading and repairing base substitution mismatches and insertion-deletion
mismatches during DNA replication and recombination [111, 112]. Inactivation of any of these MMR
related genes converts wild-type into mutator phenotype with strong mutator eﬀect. Mutator phenotypic
cells with defects inMMR exhibit mutation rate increasing 100- to 1000-fold comparing to wild-type, and
produce G:C! A:T and A:T!G:C transversions and 1–4 bp frameshift [113, 114].
This chapter uses the same novel quantitative PCR assay developed in Chapter 2 to investigate under
what circumstances mutator phenotype can achieve fixation when competing with wild-type phenotype.
An E. coli strain withmutL deletion is chosen as the mutator phenotype. MutL protein has been shown
to be an ATPase, and together withmismatch recognition proteinMutS protein, they play essential roles in
initiating repairmechanisms [114, 115]. BydeletingMutLprotein’s twoaminoacids, which lie in the region
that forms the lid of theATP-binding pocket, a study has shown thatmutation rate increasesmore than two
orders of magnitude in Salmonella typhimurium; and completely deleting mutL gene, the mutation rate is
further increased [116]. Another study using E. coli mutL deletion strain also reported more than 100-fold
increase of mutation rate using mutation-accumulation (MA) strategy, which ensures the occurrence of
mutations devoid of selective pressure[117]. In contrast, introducing high copy numbers ofmutL gene can
yield an anti-mutator phenotype withmore than twofold decrease inmutation rate compared to wild-type
[118].
Streptomycin is chosen as the antibiotic selective pressure factor for the competition experiment. Strep-
tomycin is an aminoglycoside antibiotic that aﬀects the accuracy of translation through tight interaction
with the 30S ribosomal subunit [119, 120]. Several studies have established that exposing to streptomycin
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increases the mutation rate of E. coli cells [121, 122], and one study even shows that streptomycin can fur-
ther increase the already elevated mutation rate ofmutLmutants [121].
I will start by investigating the growth behaviors of wild-type and mutators when they are grown in
isolation. Then the eﬀect of adding low concentration streptomycin (see Section 3.1.2 for details regarding
the concentration) as selective pressure will also be evaluated.
Then I will compete wild-type with mutators through serial passage with diﬀerent initial population
compositions and diﬀerent degrees of selective pressure. The selective advantage confirmed by antibiotic
resistance mutation will also be quantified through analysis of competition results.
Finally I will present a simple theoretical model of the wild-type/mutator competition simulation, and
study howmutators influence the adaption process for asexual population in a new environment by exam-
ining the eﬀects of population size, selective coeﬃcient and strength of mutator eﬀect.
3.1 Materials andMethods
3.1.1 Strains
E. coli strain BW25113 (F-,Δ(araD-araB)567,ΔlacZ4787(::rrnB-3), λ-, rph-1,Δ(rhaD-rhaB)568, hsdR514)
and JW4128-1 (F-, Δ(araD-araB)567, ΔlacZ4787(::rrnB-3), λ-, rph-1, Δ(rhaD-rhaB)568, ΔmutL720::kan,
hsdR514) were acquired from the Yale Coli Genetic Stock Center. Both the parent strain BW25113 and its
mutL knockout strain JW4128-1 came from the Keio Collection of single gene knockouts [123].
3.1.2 Growth Assays
All growth assays were carried out using Davis Minimal Broth supplemented with dextrose with a con-
centration of 1000mg L−1 (DM1000). 5X Supplement EZ (AA) from EZ Rich Defined Medium [124]
was also added to the broth at 1:4 ratio as amino acids supplement (DM1000+AA). When selective pres-
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sure is required, streptomycin sulfate (Fisher Scientific, Hampton, NH) was added into the broth to a final
concentration of 2 µgmL−1 (See Section 3.4 for details about the streptomycin concentration choice).
For separate growth experiments, overnight cultures of wild-type and mutators in DM1000+AA were
used as initial inoculum, and 2 µL of each strain was inoculated into 148 µL DM1000+AA medium and
DM1000+AAsupplementedwith2 µgmL−1 streptomycin. Thegrowthexperimentswere carriedouton96
well flat bottomCorningCostar cultureplates(Corning Incorporated,Corning,NY).Every strain/medium
combination(wild-typewithout streptomycin,mutatorwithout streptomycin,wild-typewith streptomycin
and mutator with streptomycin) was repeated in 20 wells (each well represents one collecting time point).
Toprevent evaporation and cross contamination, plateswere coveredwithbreathe easiermembranes (USA
Scientific, Ocala, FL) before putting the plate lids on. The plates were incubated on a plate shaker at
1350 rpm at 37 °C. Every 30min, 5 µL of cells from every strain/medium combination was collected from
one of the 20 repeated wells into 95 µLMilli-Q water and lysed on a dry bath at 95 °C for 5min, and stored
at −20 °C until used as template for qPCR assay.
Threediﬀerent conditionsof selectivepressurewas testedduring competitionexperiments: i)DM1000+AA
only, ii) daily alternations between DM1000+AA and DM1000+AA supplemented with 2 µgmL−1 strep-
tomycin, and iii) DM1000+AA supplemented with 2 µgmL−1 streptomycin only.
Similar to separate growthexperiments, competitionexperiments alsousedovernight cultures inDM1000+AA
as inoculum. Diﬀerent ratios ofwild-type/mutator (102:1, 101:1, 1:1, 1:101, 1:102) overnight cultureswere
mixed first in a 1.7mL tube, and 2 µL of eachmixturewas inoculated into 148 µL freshmedium into 96well
flat bottom Corning Costar culture plates. After every 24 h, 2 µL of culture from each well was transferred
into a new well with 148 µL fresh medium. After making the transfer, another 5 µL of culture from each
well was collected and diluted with 95 µLMilli-Qwater and incubated on a dry bath at 95 °C for 5min, and
stored at −20 °C until used as template for qPCR assay.
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3.1.3 Quantitative PCRAssay
For the quantitative PCR (qPCR) assay, a 10 µL qPCR reaction mixture was used, and it contained the
following components: 200 µM of each dNTP, 0.4U (per 10 µL volume) Roche FastStart Taq DNA poly-
merase (Roche Diagnostics), 1X Roche FastStart Buﬀer (Roche Diagnostics), 0.4 µM of forward and re-
verse primers (see Table 3.1 for primer details), 2 µM SYTO 9 green fluorescent nucleic acid stain (Invit-
rogen) and 2 µL of template.
All reactions were performed in a CFX Connect Real-Time PCR Detection System (Bio-Rad Labora-
tories), in 96 well, clear bottom, hard shell, skirted assay plates (Bio-Rad Laboratories) with Microseal B
sealing tape (Bio-Rad Laboratories). The instrument filter setting was set for FAM. Primers used in mu-
tator study are summarized in Table 3.1. Thermal cycles used are following: one cycle of 95 °C for 4min,
followed by 35 cycles of 95 °C for 30 s, 55 °C for 30 s, plate read, and 72 °C for 20 s.
Table 3.1: Primers used in mutator study
Primers 50 ! 30
tolC Forward CGACAAACCACAGCCGGTTA
tolC Reverse CAGCGAGAAGCTCAGGCCA
mutL Forward CACCCCGCCAAACACGAA
mutL Reverse GGACGACTGCCTGATGCT
Both tolC andmutL are chromosomal loci that are present inBW25113 (wild-type strain), howevermutL
is not present in JW4128-1 (mutL deletionmutator strain). TheCt values were converted into cell concen-
trations by using standard curve method. Standard curves of both tolC and mutL primers are generated
by using the same templates of 10-fold serial dilutions of overnight BW25113 culture with known concen-
tration ranging from 4 106 to 4 109mL−1. By relying on the linear regression equation of the known
concentration and Ct values of these serial dilutions, one can interpolate the unknown template’s concen-
tration. Because for BW25113 strain, the ratio of tolC tomutL is 1:1, by using the same templates for both
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tolC and mutL primers, we can correct for any eﬃciency diﬀerence between them.
3.2 Results
3.2.1 SeparateGrowth
Wild-type and mutator cells should both follow logistic growth (growth curves are shown in Figure 3.1
right column) if grown in isolation:
dn
dt
= rn(1  n
K
) (3.1)
where n is the cell density, r is the growth rate, and K is the cell carrying capacity. Equation (3.1) can be
rearranged with all n related terms on the left-hand side, while leaving other terms on the right-hand side:
dn
n(n  K) =
r
K
dt (3.2)
Integrating both sides yields the following linear relation:
ln K  n
n
=  rt+ C (3.3)
where C is a constant.
K can be determined by averaging the separate growth experiments’ saturation phase data (data points
after 420min in Figure 3.1 left column). The results are summarized in Table 3.2 with standard deviation
showing as uncertainty inside parentheses.
After obtainingK, the linear regressionmodel specified in Equation (3.3) can be fitted with the separate
growth experiment’s exponential phase data (data points before 270min in Figure 3.1 left column). The
absolute value of the regression slope of log-population size versus time corresponds to the growth rate r.
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Figure 3.1: Left column: time series plots of wild-type andmutL deletion mutators grow separately without
streptomycin and with low concentration of 2 µgmL−1 streptomycin as antibiotic selective pressure. Circle rep-
resents growth data point measured from qPCR using tolC primers, and red line represents the fitted curve.
Right column: corresponding linear regression model best-fit of exponential growth phase. The slope corre-
sponds to growth rate. Circle represents the transformed growth data point (see Equation (3.3) for details), and
red line represents the bet-fit line
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The best-fit lines and linear regression fitting results are summarized in Figure 3.1 right column.
One can clearly see, as expected, both wild-type and mutL deletion mutator cells exhibit decreased
growth rate when 2 µgmL−1 streptomycin is added: wild-type growth rate decreases from 0.0246min−1
to 0.0220min−1; mutator growth rate decreases from 0.0246min−1 to 0.0218min−1. But surprisingly, the
growth rates of wild-type andmutator cells are almost identical with or without streptomycin. This means
themutL deletion within themutator ancestor strain doesn’t cause either fitness advantage or disadvantage
compared to the wild-type ancestor strain when grown in DM1000+AA growth medium with or without
streptomycin. And it is because of this trait, the mutL deletion mutator is chosen among several diﬀerent
mutators for competition experiment. The fitness similarities between these two strains imply during com-
petition growth experiments, the fitness increase should come from beneficial mutations acquired during
competition.
Table 3.2: Parameter values used in separate growth fitting
Physical
Quantity
wild-type
without
Streptomycin
Mutator
without
Streptomycin
wild-type
with
Streptomycin
Mutator
with
Streptomycin
r 0.0246min−1 0.0246min−1 0.0220min−1 0.0218min−1
K 1.26(18)109mL−1 1.21(18)109mL−1 1.22(14)109mL−1 1.33(11)109mL−1
3.2.2 CompetitionGrowth
Figure 3.2 shows mutL deletion mutator and wild-type competition results after five days grouped by se-
lective pressure conditions.
Figure 3.2a shows competition resultswith no added antibiotic selective pressure. One can clearly notice
the competition results depend on the starting wild-type:mutator ratio (frequency dependent). When
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Figure 3.2: Mutator frequencies after day 5 of competition betweenmutL deletion mutator and wild-type in
DM1000+AAmedium with (a)no added streptomycin (circle), (b)no and 2 µgmL−1 streptomycin alternating
everyday (square) and (b)2 µgmL−1 streptomycin (triangle). x-axis specifies the starting wild-type:mutator
ratio at day 0, and dotted red line denotes corresponding starting mutator frequency. Black solid line denotes the
average mutator frequencies of four duplicates (symbol) after day 5
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Figure 3.3: Mutator frequencies after day 5 of competition betweenmutL deletion mutator and wild-type in
DM1000+AAmedium with no added streptomycin (SM) (circle), 2 µgmL−1 streptomycin (square) and no and
2 µgmL−1 streptomycin alternating everyday (triangle) with starting ratio of wild-type:mutator (a)10:1, (b)1:1
and (c)1:10. x-axis specifies the selective pressure condition. Dotted red line denotes starting mutator frequency
at day 0, and black solid line denotes the average mutator frequencies of four duplicates (symbol) after day 5
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starting withmajority of wild-type cells (wild-type:mutator 100:1 and 10:1), at the end of day 5, wild-type
cells still outnumber mutator cells (wild-type:mutator3:2). But when starting with majority of mutator
cells (wild-type:mutator 1:10 and 1:100), at the end of day 5, mutator cells still constitute a very large
portion of the population (wild-type:mutator sim1:9). When starting with comparable amount of wild-
type andmutator cells (wild-type:mutator 1:1), at the end of day 5, the competition outcome is stochastic
but the winning margin is always small, with wild-type or mutator represent between 40–60% of the total
population. To summarize competitionwithout selective pressure, neitherwild-type normutator can drive
the other to extinction but approaches equilibrium determined by the starting ratio.
Figure 3.2b shows competition results with alternating everyday between no antibiotics and 2 µgmL−1
added streptomycin. Under this condition, at the end of day 5, mutator cells always outperform wild-type
under all three starting ratios tested (wild-type:mutator 10:1, 1:1 and 1:10). This suggests that under se-
lective condition, mutator cells confirm a higher fitness due to acquired beneficial mutations.
Figure 3.2c shows a clearer picture of mutator cells’ fitness advantage through elevated mutation rate
when streptomycin is present at all time. The five diﬀerent starting ratios (wild-type:mutator 100:1, 10:1,
1:1, 1:10 and 1:100) all share the same outcome: at the end of day 5, mutator cells drive the wild-type
almost to extinction with final population almost 100%mutator cells.
Figure 3.3 re-plots Figure 3.2 but grouped by starting wild-type:mutator ratios (10:1, 1:1 and 1:10).
All three ratios exhibit the same trend: as the level of selective pressure increases (without streptomycin,
alternate streptomycin, with streptomycin), mutator cells’ final frequency also increases.
Inorder to see thedynamics of the competitionbetweenwild-type andmutator cells, selected time series
of mutator frequencies from day 0 to day 10 are shown in Figure 3.4.
In the absence of streptomycin as selective pressure, neitherwild-type normutator can drive the other to
extinction. After 10 days of competition, wild-type andmutator reached equilibriumwith a relatively fixed
ratio (Figure 3.4 first column). But when streptomycin is added every other day, mutator starts to drive
wild-type to extinction by acquiring beneficial mutations faster through elevatedmutation rate (Figure 3.4
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second column). When streptomycin is present in the media constantly, the rate of the whole population
converging to mutator increases (Figure 3.4 third column).
From a more quantitative view point, Figure 3.4 can be used to estimate fitness eﬀects of mutations by
relating to the selection coeﬃcient s. Consider an asexual population consisting of mutator and wild-type
cells with frequencies p and q = 1  p. The selection coeﬃcient s of this continuous growth culture can be
defined as:
s = d
dt
ln p
q
=
d
dt
ln p
1  p (3.4)
[125], with the units of time−1. If s > 0, mutator cells have fitness advantage comparing to wild-type. If
s < 0, mutator cells have fitness disadvantage comparing to wild-type.
Thedefinitionof selection coeﬃcient sof continuous growth fromEquation (3.4) can alsobe formulated
equivalently for discrete non-overlapping generations:
sT = ln

p0=(1  p0)
p=(1  p)

(3.5)
[126], with primes denotes the values in the next generation. Here sT represents the selection coeﬃcient
is evaluated over generation time, and therefore has the units of generation−1.
For the serial passage competition assay used in this experiment, the number of generations T between
each passage can be estimated using the dilution factorD = 75:
T = log2 D = log2 75 (3.6)
And the ratio of mutator and wild-type cells at the end of day k-1 before dilution is the same as the ratio at
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the beginning of day k:
pday k-1, f=(1  pday k-1, f) = pday k, i=(1  pday k, i) (3.7)
with subscripts i and f denote the initial and finial states of each passage. Therefore, the selection coeﬃcient
evaluated over one passage is:
sT =
1
T
ln

pday k, f=(1  pday k, f)
pday k, i=(1  pday k, i)

sT =
1
T
ln

pday k, f=(1  pday k, f)
pday k-1, f=(1  pday k-1, f)

(3.8)
and the subscript f can be omitted from now on.
Because Figure 3.4 is sampled at a rate of one datum point per two days, the estimation of selection
coeﬃcient calculated from it also has to be modified as following:
sT =
1
2T
ln

pday k=(1  pday k)
pday k-2=(1  pday k-2)

(3.9)
In the absence of streptomycin as selective pressure, the selection coeﬃcient gradually converges to zero,
which signals the ratio between mutator and wild-type cells approaching equilibrium (Figure 3.5 first col-
umn). After equilibrium is reached, the mutator frequency should stay constant. When streptomycin is
added every other day, the selection coeﬃcient stays around 0.05, which roughly represents mutator cells
have about 5 % fitness advantage per generation compared to wild-type under this condition (Figure 3.5
second column). When streptomycin is present at all times, the selection coeﬃcients of all cell cultures
have a even more sizable increase with an value between 0.15 to 0.20, which represents about 15 to 20%
mutator fitness advantage per generation compared towild-type in this situation (Figure 3.5 third column).
Recall the growth rates of separate growth: both wild-type and mutator grow at 0.0246min−1 without
streptomycin; when streptomycin is present, they growat 0.0220min−1 and0.0218min−1 respectively. This
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means when growing at the presence of streptomycin, if the cell picks up the beneficial resistancemutation
that oﬀsets the growth penalty due to streptomycin, the cell will have an increase of growth rate. And the
selective coeﬃcient of streptomycin resistant type of cell compared to streptomycin non-resistant one can
be estimated as
sT = (rResistant   rNon-resistant)T
=
rResistant   rNon-resistant
rNon-resistant
ln 2 (3.10)
[126], where T = ln 2=rNon-resistant is the generation time of streptomycin non-resistant cells, and it has
units of generation−1 as in Equation (3.9). The selective coeﬃcient confirmed by acquiring a streptomycin
resistance mutation can be calculated for wild-type and mutators:
sT,WR,W =
rWR   rW
rW
ln 2 = 0:0246  0:0220
0:0220
ln 2 = 0:08 (3.11)
sT,MR,M =
rMR   rM
rM
ln 2 = 0:0246  0:0218
0:0218
ln 2 = 0:09 (3.12)
where the subscripts in sT,WR,W denotes the selective coeﬃcient between resistant wild-type (WR) and
wild-type(W)measured in terms ofwild-type(W) generation time. And similarly, the subscripts in sT,MR,M
represents the selective coeﬃcient between resistant mutators (MR) andmutators(M)measured in terms
ofmutator(M) generation time. Notice these estimated selective coeﬃcient values are smaller than 0.15 to
0.20, the values estimated from competition experiment under streptomycin condition. See Discussions
for possible reasons behind this discrepancy.
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3.3 Simulation
The aim of this section is to quantify the eﬀects of important parameters for the competition experiment
between mutator and wild-type cells under selective pressure. By modifying a theoretical model for evo-
lution in single-peak adaptive landscape[56], I will examine the influence of mutator phenotype on the
adaptation process in a finite asexual population.
3.3.1 Simulation Algorithm
The population starts with only wild-type and mutator cells without antibiotic resistance, and then selec-
tive pressure (streptomycin) is added. When beneficial mutation (streptomycin resistance) arises, it en-
ables its bearing cell selective advantage s. From generation t to generation t+ 1, the population undergoes
three processes: replication-selection, mutation and random sampling. The simulation tracks the number
of individuals of the four diﬀerent genotypes present within the population: Wild-type nW, Wild-type Re-
sistant to streptomycin nWR, Mutator nM andMutator Resistant to streptomycin nMR. Figure 3.6 shows the
schematic of the simulation algorithm, and the details of each process are described below.
Replication-Selection Process: At generation t, the number of individuals of genotype starts with ni
(i = W;WR;M;MR). After replication-selection process, the number of individuals of genotype n0i is
randomly drawn from a Poisson distribution with expected value of
E[n0i] = ni(1+ si) (3.13)
where si is the selective coeﬃcient. Wild-type and mutator before acquiring streptomycin resistance both
have the same fitness of 1, therefore sW = sM = 0. Streptomycin resistancemutation increases their fitness
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Figure 3.6: Schematic of the simulation algorithm of competition between mutator and wild-type cells under
selective pressure. The population consists of four genotypes: Wild-type (W), Wild-type Resistant to strepto-
mycin (WR), Mutator (M) andMutator Resistant to streptomycin (MR). From generation t to generation t + 1,
each genotype undergoes replication-selection, mutation and random sampling process Figure 3.5. See details of
each process in text Section 3.3.1
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by the same selective coeﬃcient sWR = sMR = s. Specifically, apply Equation (3.13) to each genotype:
E[n0W] = nW (3.14a)
E[n0WR] = nWR(1+ s) (3.14b)
E[n0M] = nM (3.14c)
E[n0MR] = nMR(1+ s) (3.14d)
Mutation Process: The number of individuals of each genotype after mutation n00i comes from two
diﬀerent sources. Some cell population come from their original type iwhich do not go throughmutation,
and the other population come fromother type jmutate into type i. Thenumber of individuals of genotype
after mutation is also drawn randomly from a Poisson distribution with expected value of
E[n00i ] = n0i(1  μi) +
X
j6=i
n0jμj!i (3.15)
where μi is the mutation rate of type i mutates to other types, and μj!i is the mutation rate of type j mu-
tates to type i. The model here only have two possible mutation paths: wild-type acquires streptomycin
resistance through mutation at rate μ, and mutator acquires the same resistance but at an elevated ratemμ.
m is the strength of mutator eﬀect, and it describes mutators’ fold increase of mutation rate comparing to
wild-type. Equation (3.15) can also be simplified for each genotype:
E[n00W] = n0W(1  μ)  n0Wμ (3.16a)
E[n00WR] = n0WR + n0Wμ (3.16b)
E[n00M] = n0M(1  mμ)  n0Mmμ (3.16c)
E[n00MR] = n0MR + n0Mmμ (3.16d)
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Random Sampling Process: The random sampling process is used tomodel drift as to keep the popu-
lation size fixed at each generation. Ideally this should bemodeled as random sampling of sizeN, the popu-
lation carrying capacity, without replacement from the total population after mutation process
P
i n00i . But
for bacteria,N is too large that the simulation time is too long to be practical for following the exact process.
Here I make the simplification by following previous two processes of drawing the number of individuals
of each phenotype randomly from a Poisson distribution with expected value of
E[n000i ] = n00i
NP
j n00j
(3.17)
The rationality behind this is to keep the sumof expected individuals of generation t+1 equal to the carrying
capacity
P
i E[n000i ] = N. Equation (3.17) can be written out in details for each genotype:
E[n000W] = n00W
N
n00W + n00WR + n00M + n00MR
(3.18a)
E[n000WR] = n00WR
N
n00W + n00WR + n00M + n00MR
(3.18b)
E[n000M] = n00M
N
n00W + n00WR + n00M + n00MR
(3.18c)
E[n000MR] = n00MR
N
n00W + n00WR + n00M + n00MR
(3.18d)
After random sampling process, the number of individuals of each genotype n000i is fed back as ni for next
round of simulation. Simulation stops until either mutator or wild-type cells become extinct, it also stops
when preset upper-limit of simulation rounds (500 generations) reaches.
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Figure 3.7: (a) Histogram of final mutator frequency of wild-type/mutator competition for diﬀerent pop-
ulation size. (b) Probability of fixation of mutators (black circle) and percentage of resistant mutators (red
square) for diﬀerent population size. Mutators are fixed when at the end of simulation the mutator consists
more than 95% of the final population. Probability of fixation of mutators are estimated as the percentage of
occurrences when mutator cells reach fixation over 500 independent simulations. Percentage of resistant mu-
tators is calculated from simulations when mutators reach fixation. Other parameters used in the simulation:
s = 0:15; μ = 1 10 8;m = 100
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3.3.2 Simulation Results
Eﬀects of population sizeN
The eﬀect of population sizeN on the fixation of mutators are examined by following population size rang-
ing from 102 to 1010 cells, which consist of half wild-type and half mutators. Mutators are said to be fixed
if at the end of 500-generation simulation, mutators reach above 95% of the total population. Parameter
values used in the simulation are chosen as following: selective coeﬃcient s = 0:15 is chosen to resem-
ble the values obtained from separate growth experiments from Section 3.2.1; beneficial mutation rate
μ = 1 10 8 is the usual estimated values used in similar simulation studies [55, 56, 73]; strength of
mutator eﬀectm = 100 is chose as the same magnitude of reported value ofmutLmutator [116, 117].
Figure 3.7a shows a histogram of final mutator frequency for diﬀerent sizes of population. Final here
means either after500-generation simulationor eithermutatororwild-type cells becomeextinct, whichever
of these two happens first. As one can see for small population sizesN < 103, fixation of either wild-type
or mutator cells is usually reached with equal probability (first and last bars of each histogram represents
the probability of fixation of wild-type and mutators respectively). When the population size starts to in-
crease N = 104 the probability of either wild-type and mutator cells becoming fixed decreases, and most
of the time, at then end of 500-generation simulation, both genotypes co-exist within the population. But
as population size increases beyond N > 105, the probability of mutators driving wild-type to extinction
and becoming fixed approaches 1.
Figure 3.7b summaries the probability of fixation of mutators for diﬀerent population sizes. It is gener-
ated from Figure 3.7a by plotting the last bar (represents the frequency of mutator consisting more than
95% of the population at the end of simulation) versus population size (black circle). But one has to be
careful when interpreting the relation between these two quantities. For small population size cases, the
final fixedmutator population is dominated bymutator cells that lack the resistancemutation, and the fixa-
tion is due to drift. Whereas for large population sizes, the fixedmutators are dominantly resistant mutator
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cells. This can be easily seen by plotting the percentage of resistant mutators for the cases when mutator
cells become fixed (red square). As the population size increases, the percentage of resistant mutators also
increases, but not necessarily, the probability of fixation of mutators.
Eﬀects of selective coeﬃcient s and strength ofmutator eﬀectm
5 10 20 40 80 160 320 640 1280
0
0.2
0.4
0.6
0.8
1
Strength of Mutator Effect
Pr
ob
ab
ilit
y 
of
 F
ixa
tio
n 
of
 M
ut
at
or
Figure 3.8: The eﬀect of selective coeﬃcient and strength of mutator eﬀect on the probability of fixation of mu-
tators (over 200 independent simulations). The strength of mutator eﬀectm is set at log scale on x-axis. Each
plot represents a diﬀerent selective coeﬃcient s: 0.01 (circle), 0.03 (square), 0.05 (diamond), 0.09 (upward-
triangle), 0.15 (downward-triangle). Other parameters used in the simulation: N = 1 108;m = 100
Figure 3.8 shows the eﬀect of selective coeﬃcient s and strength of mutator eﬀectm on the probability
of mutator fixation. The population size is fixed at 1 108, which is the estimated number of the actual
population size in each growth well for competition experiments in Section 3.1.2 (109mL 1 10 1mL 
108).
When the selective coeﬃcient is small s = 0:01, the fitness advantage of acquiring this beneficial mu-
tation does not have any impact on helping mutator cells become fixed, even for mutator cells with more
than 1000-foldmutation rate increase. Mutator andwild-type cells co-exist without either of them arriving
at fixation. As the value of selective coeﬃcient increases, the probability of mutator fixation also increases,
and the strength ofmutator eﬀectm becomes the limiting factor (s = 0:05; 0:09; 0:15 points almost overlap
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each other in Figure 3.8). The strength of mutator eﬀectm here limits the upper limit of the probability of
mutator fixation. For a specific value ofm, as s increases, the probability of mutator fixation also increases,
but cannot go above this upper limit value.
3.4 Discussion
This chapter presented an excellent example of utilizing the novel qPCR assay developed in Chapter 2 to
investigate the role of spontaneousmutation on howmutator phenotype with elevatedmutation rate com-
pete with wild-type for fixation. By introducing non-lethal concentration of streptomycin as selective pres-
sure, the competition outcomes turned from co-existence of wild-type and mutators to mutators driving
wild-type to extinction as a result of mutators acquiring beneficial mutations faster through elevated mu-
tation rate. Beneficial mutations are far rarer comparing to mutations with negative or negligible fitness
eﬀects, therefore are studied with diﬃculty. The experiment setup with the choice of mutators and choos-
ing streptomycin as antibiotic selection helped the observation of beneficial mutation eﬀect in reasonably
short time span.
The concentration of streptomycin 2 µgmL−1 was chosen to be on the lower spectrum of minimal in-
hibitory concentration (MIC) for E. coli (2–4 µgmL−1)[127] to insure the concentration is low enough
that bothwild-type andmutators can growwithout acquiring any beneficialmutation but also high enough
to pose growth pressure that both phenotypes show decreased growth rate. A study investigatedmore than
900 E. coli isolates from meat and meat products with streptomycin MICs vary from 2 µgmL−1 to more
than 256 µgmL−1 depending on the genetic background, and showed about 86% strains with a low strep-
tomycinMIC of 8 µgmL−1 [128]. Therefore low streptomycin concentration alsomakes cells to acquire
streptomycin resistance more easily.
By growing wild-type and mutator cells separately in media with and without added streptomycin, I es-
timated selective coeﬃcients sT,WR,W = 0:08) (Equation (3.11)) and sT,MR,M = 0:09 (Equation (3.12))
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of the streptomycin resistant mutants compared to non-resistant phenotype. By competing wild-type and
mutator cells together, I estimated that under streptomycin selective pressure, mutator cells comparing
to wild-type eventually exhibited a selective coeﬃcient about sT,Resistant,Non-resistant 0.15 to 0.20 (Fig-
ure 3.5 third column)). The estimated values are smaller from competitive growth than those from separate
growth. This discrepancy between these two sets of values comes from two sources.
First, the subscripts clearly show these selection coeﬃcients cannot be compared directly. In order to
compare them, two assumptions have to be justified. First, when grown separately, wild-type and muta-
tor cells are indistinguishable in terms of growth rates in media both with and without antibiotics (rW =
rM; rWR = rMR), which leads to sT,WR,W = sT,MR,M = sT,Resistant,Non-resistant. This assumption is true to a
great extent as the growth rates of wild-type and mutators are alike (Table 3.2) and numerically the two
estimated selective coeﬃcient values are very close 0:08  0:09. The second assumption concerns the
competition experiment. The selective coeﬃcient is calculated between resistant and non-resistant pheno-
type. However, both resistant and non-resistant phenotype are a mixture of mutator and wild-type pheno-
types. But as the competition progress, most resistant phenotype arise from mutators and most mutators
become resistant, whereas most wild-type stay non-resistant phenotype. Under this assumption, the resis-
tant phenotype only corresponds to resistantmutators, and the non-resistant phenotype only corresponds
to non-resistant wild-type. The selective coeﬃcient becomes sT,Resistant,Non-resistant = sT,MR,W. This assump-
tion matches the simulation result as shown in Section 3.3.2.
Second, the estimated selective coeﬃcient from separate growth experiments are calculated according
to Equation (3.10) using the intrinsic growth rates of the two phenotypes when grown in isolation. This
is equivalent to say that using Equation (3.10) to calculate selection coeﬃcient assumes the nature of se-
lection is frequency-independent. Frequency-independent selection here means there are no interactions
between these two genotypes that are competing when grown together. However, from the competition
experiment without streptomycin condition, we can see this assumption is not satisfied. Figure 3.4 first
column showswithout added selective pressure, diﬀerent starting ratios will result in diﬀerent competition
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results. This starting ratio dependency implies there are interactions between wild-type and mutator phe-
notypes when grown together. It also further indicates the selective coeﬃcient estimated value from com-
petition experiments is the combination of fitness advantage of resistancemutation andwild-type/mutator
interactions. Theextracted selective coeﬃcient values 0.15 to0.20 are fromexperimentswith startingmuta-
tor frequency less than equilibriummutator frequency, and in this case, these values overestimated the true
selective coeﬃcient due to resistantmutation by including the other part of contribution from interactions
between wild-type and mutators. Therefore, the actual selective coeﬃcient due to beneficial resistance
mutation from competition experiments should be less than 0.15.
It may seem surprising that mutator cells can reach fixation in such a short period of time under strepto-
mycin selective pressure. Previous experimental work has also shown that mutators have 500-fold increase
under selection of rifampin resistance [71]. To understand these results, one has to remember that the
nature of adaption is organisms move toward the phenotype that best fits the current environment [129].
When adaptation is reached, nomatter what the shape of the distribution of fitness is, the organism should
reside at the right tail, and any beneficial mutation has to draw from the even more extreme values of that
tail [130, 131]. Therefore, mutators do not have advantage if the competition happens in an environment
in which wild-type is already adapted, simply because the possible beneficial mutations are limited by the
fitness distribution right tail. However, for a novel environment in which neither wild-type or mutators
are adapted, they no longer reside at the right tail of fitness distribution, and mutators’ elevated mutation
rate enables them to sample the beneficialmutations with higher probability compared towild-type. Intro-
ducing antibiotic selective pressure is essentially shifting both wild-type and mutators away from the right
tail of fitness distribution, and opens up the beneficial mutation spectrum bymeans of antibiotic resistance
mutations.
One can also look at this from a simple mathematical model: a population of mixtures of mutators and
wild-type is going through lethal antibiotic selection. Before selection, the frequencies ofmutator andwild-
type cells are p and 1   p respectively. If the beneficial antibiotic resistance mutation rates are u for wild-
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type andmu for mutators, wherem is the mutation rate fold increase due to mutator phenotype (strength
of mutator eﬀect). For lethal antibiotic selection, only antibiotic resistance mutant phenotype can sur-
vive. Therefore after selection, the wild-type frequency is (1   p)u, and mutator frequency is pmu. After
normalizing, the mutator frequency after selection p0 becomes
p0 = pmu
(1  p)u+ pmu
=
pm
1  p+ pm (3.19)
The mutation rate u canceled out, and the mutator frequency after lethal antibiotic selection only de-
pends on themutator frequency before selection p and strength ofmutator eﬀectm. Figure 3.9 plots Equa-
tion (3.19) for diﬀerent values of strength of mutator eﬀect m. If mutator has no eﬀect on mutation rate
(m = 1), themutator frequency does not change after selection. Asmutator eﬀectm increases, themutator
frequency after selection also increases for the same starting mutator frequency. For natural population,
mutator frequency is very low, the absolute increasemay seem small. But if mutator constitutes 10% of the
population, then after selection the mutator can increase to around 90% for m = 100. By selecting for a
specificmutant phenotype, the proportion of mutators can be greatly increased in that selected population
as a result of mutators’ elevated mutation rate.
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Figure 3.9: Mutator frequency increases after lethal selection. Each curve represents diﬀerent mutator eﬀect.
As mutator eﬀect increases, mutator frequency after selection also increases if starting at the same mutator fre-
quency before selection
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4
Epilogue
In 1945, Sir Alexander Fleming shared the Nobel Prize in Physiology orMedicinewithErnst
Boris Chain and SirHowardWalter Florey “for the discovery of penicillin and its curative eﬀect in various
infectious diseases” [132]. In his Nobel Lecture, Fleming gave the note of warning [133]:
The time may come when penicillin can be bought by anyone in the shops. Then there is
the danger that the ignorant manmay easily underdose himself and by exposing his microbes
to non-lethal quantities of the drug make them resistant. Here is a hypothetical illustration.
Mr. X. has a sore throat. He buys some penicillin and gives himself, not enough to kill the
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streptococci but enough to educate them to resist penicillin. He then infects his wife. Mrs. X
gets pneumonia and is treated with penicillin. As the streptococci are now resistant to peni-
cillin the treatment fails. Mrs. X dies. Who is primarily responsible for Mrs. X’s death? Why
Mr. X whose negligent use of penicillin changed the nature of the microbe. Moral: If you use
penicillin, use enough.
Fleming was right about warning the negligent use of antibiotics. Doctors around the world over-prescribe
antibiotics to patients. People inappropriate use of antibiotics are still widespread. The food industry and
farmers indiscriminately use low dose of antibiotics on livestock. Now Fleming’s warning has become the
reality: the golden age of antibiotics discovery has faded, the spread of superbugs are rising. “In essence,
we are engaged in an arms race with pathogenic bacteria—– and we are losing.”[134]
“The emergence of antibiotic resistance is themost eloquent example of Darwin’s principle of evolution
that there ever was,” says David Livermore, director of the antibiotic resistance monitoring and reference
laboratory of the Health Protection Agency (now part of Public Health England). “It is a war of attrition.
It is naive to think we can win.” [135] New antibiotic resistance is constantly generated throughmutations
with mutator phenotype accelerating this process. Horizontal gene transfer facilitates the spread of the
newly arising resistance gene among bacteria. We have to start look beyond antibiotics, and start to explore
othermethods to keep bacteria at bay. Hopefully this thesis can contribute to this process by providing new
methods and insight on the kinetics of evolutionarymechanisms of bacteria. We need to hurry up, because
the post-antibiotic era is coming.
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